Vinay Prasad, the new director of the Center for Biologics Evaluation and Research, delivered his first address to FDA staff with a tone of humility and admiration for the agency’s employees. In a recording obtained by STAT, Prasad expressed his commitment to evidence-based medicine and epidemiology, highlighting his respect for the work done by FDA staff over the years.
During his address, Prasad emphasized the importance of serving the American public, referring to them as the agency’s “number one stakeholder.” He acknowledged the valuable contributions of FDA employees and expressed his eagerness to work alongside them to uphold the agency’s mission of protecting public health.
Prasad’s remarks stood in contrast to his online persona as a firebrand, showcasing a more introspective and earnest side. He praised the agency staff for their dedication and expertise, stating that he had learned a great deal from reading their research papers over the past two decades.
The new director’s emphasis on evidence and his genuine appreciation for the work of FDA employees set a positive tone for his leadership. His commitment to serving the American public and upholding the agency’s core values bodes well for the future of the Center for Biologics Evaluation and Research under his guidance.
As Prasad takes on his new role, his address to FDA staff serves as a promising start to his tenure. By valuing evidence, respecting the agency’s employees, and prioritizing the needs of the American public, he sets a strong foundation for fulfilling the FDA’s vital mission of ensuring the safety and efficacy of biologic products.
